Q1 2020 DiaMedica Therapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics conference call to discuss the top line results from DiaMedica's REMEDY Phase II clinical study in acute ischemic stroke and first quarter results. An audio recording of the webcast and a copy of the slide presentation will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investors section. I would now like to hand the call over to Rick Pauls, President and CEO. Please go ahead, sir.
Thank you, Lisa, and good morning, everyone, and thank you for attending today's presentation. Before the company proceeds with our remarks, please note that the company will be making forward-looking statements on today's call. These statements are participant to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |